This announcement is a separate document:
美康九州医药有限公司拟股权转让涉及的上海新兴医药股份有限公司股东全部权益价值项目资产评估报告
Asset evaluation report of all shareholders' equity value projects of Shanghai Xinxing Pharmaceutical Co., Ltd. involved in the proposed equity transfer of Meikang Jiuzhou Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.